Search Results for: Anil Potti

Update: Potti’s South Carolina medical license now listed as active

Updated at 1:40 p.m. Eastern: When original posted, this item reported, correctly, that the South Carolina Board of Medical Examiners’ website listed Anil Potti’s license as “suspended.” However, that status has now been changed to “active,” along with “No disciplinary action taken by the Board. This certifies that the above licensee is in good standing.” We are … Continue reading Update: Potti’s South Carolina medical license now listed as active

Tenth Potti retraction appears, in Clinical Cancer Research

Anil Potti and his colleagues have retracted another paper, “Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma,” originally published in the December 15, 2009, issue of Clinical Cancer Research. According to the notice:

Potti and colleagues retract 2008 JAMA paper

Anil Potti‘s retraction count is now eight with the withdrawal of a 2008 study in the Journal of the American Medical Association (JAMA). Here’s the notice, which appeared online in JAMA sometime yesterday:

New in PNAS: Potti retraction number seven, and a Potti correction

The Proceedings of the National Academy of Sciences (PNAS) has published the seventh retraction for former Duke researcher Anil Potti, who now faces a lawsuit in the midst of an ongoing investigation into his work: Retraction for “A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities,” by Katherine S. Garman, … Continue reading New in PNAS: Potti retraction number seven, and a Potti correction

Potti retraction tally grows to six with a withdrawal in PLoS ONE, and will likely end up near a dozen

Anil Potti and his former Duke colleagues have retracted a sixth paper, this one in PLoS ONE. According to the retraction notice for “An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer,” the withdrawal was prompted by the retraction of a Nature Medicine paper that formed the basis of the … Continue reading Potti retraction tally grows to six with a withdrawal in PLoS ONE, and will likely end up near a dozen

Duke sued over Potti case

From the “not terribly surprising” department: Eight patients — or their estates — who enrolled in clinical trials at Duke overseen by Anil Potti and colleagues have sued the university. The 90-page lawsuit, which names Duke, Potti, Potti’s boss Joseph Nevins, CancerGuide Diagnostics (in which Potti and Nevins had an interest), among others, does a thorough job of documenting … Continue reading Duke sued over Potti case

No Potti retractions on the horizon from JAMA, NEJM

With the third retraction of a paper by Anil Potti this weekend, plus details of various investigations dribbling out, we decided to check in with the world’s two leading medical journals about whether they planned to retract the papers of Potti’s they’d published. JAMA published two papers by Potti and colleagues: One, “Gene Expression Signatures, … Continue reading No Potti retractions on the horizon from JAMA, NEJM

A retraction in the Potti case?

In our very first post, we noted the case of Anil Potti, a Duke researcher who posed as a Rhodes Scholar and appears to have invented key statistical analyses in a study of how breast cancer responds to chemotherapy[.The case] has sent ripples of angst through the cancer community. Potti’s antics prompted editors of The … Continue reading A retraction in the Potti case?